Eriocitrin from lemon suppresses the proliferation of human hepatocellular carcinoma cells through inducing apoptosis and arresting cell cycle

Cancer Chemotherapy and Pharmacology

Volumn 78, Issue 6, 2016, Pages 1143-1150

  Wang, Ziyou ^a,b   Zhang, Hua ^a,b   Zhou, Jiahui ^a,b   Zhang, Xiangning ^a,b   Chen, Liyong ^a,b   Chen, Kangxing ^a,b   Huang, Zunnan ^a,b  

^a Key Laboratory for Medical Molecular Diagnostics of Guangdong Province   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle arrest; Eriocitrin; Hepatocellular carcinoma

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 1; ANTIMITOTIC AGENT; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 7; CASPASE 9; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN A; CYCLIN D3; CYCLIN DEPENDENT KINASE 6; ERIOCITRIN; FLAVONOID; PROTEIN P53; UNCLASSIFIED DRUG; ATF1 PROTEIN, HUMAN; CASPASE; CREB1 PROTEIN, HUMAN; FLAVANONE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; HEPG2 CELL LINE; HUMAN; HUMAN CELL; LEMON; LIVER CELL CARCINOMA; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; S PHASE CELL CYCLE CHECKPOINT; UPREGULATION; CELL CYCLE CHECKPOINT; CELL TRANSFORMATION; CHEMISTRY; CITRUS; DRUG EFFECT; HEP-G2 CELL LINE; LIVER TUMOR; MAPK SIGNALING; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

ACTIVATING TRANSCRIPTION FACTOR 1; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASES; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CITRUS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FLAVANONES; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION;

EID: 84991794158     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-016-3171-y     Document Type: Article

References (34)

1. World Health Organization (WHO) (2014) Global battle against cancer won’t be won with treatment alone effective prevention measures urgently needed to prevent cancer crisis. Cent Eur J Publ Health 22(23):28
2. Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379:1245–1255
3. Llovet JM, Bruix J (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48:1312–1327
4. Lu SC (2010) Where are we in the chemoprevention of hepatocellular carcinoma? Hepatology 51:734–736
5. Song MJ (2015) Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma. World J Gastroenterol 21:3843–3849
6. Key TJ (2010) Fruit and vegetables and cancer risk. Br J Cancer 104:6–11
7. Reddy L, Odhav B, Bhoola KD (2003) Natural products for cancer prevention: a global perspective. Pharmacol Ther 99:1–13
8. Lee KW, Bode AM, Dong Z (2011) Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer 11:211–218
9. Gonzalez-Molina E, Dominguez-Perles R, Moreno DA, Garcia-Viguera C (2010) Natural bioactive compounds of Citrus limon for food and health. J Pharm Biomed Anal 51:327–345
10. Li C, Zug C, Qu H, Schluesener H, Zhang Z (2015) Hesperidin ameliorates behavioral impairments and neuropathology of transgenic APP/PS1 mice. Behav Brain Res 281:32–42
11. Bacanli M, Basaran AA, Basaran N (2015) The antioxidant and antigenotoxic properties of citrus phenolics limonene and naringin. Food Chem Toxicol 81:160–170
12. Banjerdpongchai R, Wudtiwai B, Khaw-On P, Rachakhom W, Duangnil N, Kongtawelert P (2016) Hesperidin from Citrus seed induces human hepatocellular carcinoma HepG2 cell apoptosis via both mitochondrial and death receptor pathways. Tumour Biol 37(1):227–237
13. Miyake Y, Yamamoto K, Tsujihara N, Osawa T (1998) Protective effects of lemon flavonoids on oxidative stress in diabetic rats. Lipids 33:689–695
14. K-i Minato, Miyake Y, Fukumoto S, Yamamoto K, Kato Y, Shimomura Y et al (2003) Lemon flavonoid, eriocitrin, suppresses exercise-induced oxidative damage in rat liver. Life Sci 72:1609–1616
15. Hiramitsu M, Shimada Y, Kuroyanagi J, Inoue T, Katagiri T, Zang L et al (2014) Eriocitrin ameliorates diet-induced hepatic steatosis with activation of mitochondrial biogenesis. Sci Rep 4:3708
16. Wang Y, Yu H, Zhang J, Gao J, Ge X, Lou G (2015) Hesperidin inhibits HeLa cell proliferation through apoptosis mediated by endoplasmic reticulum stress pathways and cell cycle arrest. BMC Cancer 15:682
17. Schrödinger Release 2015-2 (2015) Maestro, version 10.2, Schrödinger, LLC, New York
18. Whitfield ML, George LK, Grant GD, Perou CM (2006) Common markers of proliferation. Nat Rev Cancer 6:99–106
19. Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL (2011) Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 11:558–572
20. Lee J, Kim SS (2009) The function of p27 KIP1 during tumor development. Exp Mol Med 41:765–771
21. Chen J (2016) The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression. Cold Spring Harb Perspect Med 6(3):a026104
22. Shalini S, Dorstyn L, Dawar S, Kumar S (2014) Old, new and emerging functions of caspases. Cell Death Differ 22:526–539
23. Delbridge AR, Grabow S, Strasser A, Vaux DL (2016) Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. Nat Rev Cancer 16:99–109
24. Liu K, Cho YY, Yao K, Nadas J, Kim DJ, Cho EJ et al (2011) Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation. J Biol Chem 286:2057–2066
25. Bruix J, Han KH, Gores G, Llovet JM, Mazzaferro V (2015) Liver cancer: approaching a personalized care. J Hepatol 62:S144–S156
26. Demain AL, Vaishnav P (2011) Natural products for cancer chemotherapy. Microb Biotechnol 4:687–699
27. O’Leary B, Finn RS, Turner NC (2016) Treating cancer with selective CDK4/6 inhibitors. Nat Rev Clin Oncol 13(7):417–430
28. Malumbres M, Barbacid M (2005) Mammalian cyclin-dependent kinases. Trends Biochem Sci 30:630–641
29. Mateo F, Vidal-Laliena M, Canela N, Busino L, Martinez-Balbas MA, Pagano M et al (2009) Degradation of cyclin A is regulated by acetylation. Oncogene 28:2654–2666
30. Hydbring P, Malumbres M, Sicinski P (2016) Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases. Nat Rev Mol Cell Biol 17(5):280-292
31. Inoue S, Browne G, Melino G, Cohen GM (2009) Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway. Cell Death Differ 16:1053–1061
32. Sebolt-Leopold JS, Herrera R (2004) Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 4:937–947
33. Manson MM (2003) Cancer prevention—the potential for diet to modulate molecular signalling. Trends Mol Med 9:11–18
34. Henderson AJ, Ollila CA, Kumar A, Borresen EC, Raina K, Agarwal R et al (2012) Chemopreventive properties of dietary rice bran: current status and future prospects. Adv Nutr: Int Rev J 3:643–653